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Abstract
Background: Studies have shown that Na+-K+ ATPase activity was altered in disrupted red blood cell membranes and this 
enzyme is believed to be the site of  active transport of  Na+ and K+ in intact red blood cells.  The enzyme is often referred to as 
Na+- K+ pump because it pumps Na+ out and K+ into the cell against gradients with the concomitant hydrolysis of  intracellular 
ATP. 
Objective: The aim of  this study was to find out the possibility of  using Na+-K+-ATPase activity as a biomarker for the diagno-
sis of  individuals with different physiological conditions.
Materials and methods: The activity of  Na+-K+ ATPase was determined in blood samples collected from different patholog-
ical and physiological conditions such as pregnancy, smoking, diabetes and renal dysfunction compared with healthy subjects 
matched for age and sex.  
Results: The Na+-K+ ATPase activity in pregnancy (0.094 ± 0.0051 µM Pi/min. mg protein), smoking (0.064 ± 0.0011 µM), 
diabetes (0.047 µM 0.002 µM) and kidney disease (0.069 ± 0.0014 µM) was higher compared to the measurements in healthy 
individuals (0.0081 ± 0.0031 µM).
Conclusion: Na+- K+ATPase specific activity is a biomarker for the diagnosis of  individuals with different physiological diseases.
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Studies have shown that Na+-K+-ATPase activity was 
altered in disrupted red blood cell membranes1 and this 
enzyme can be the site of  active transport of  Na+ and 
K+ in intact red cells2.  The enzyme is often referred to 
as Na+- K+ pump because it pumps Na+ out and K+ into 
the cell against gradients with the concomitant hydrolysis 
of  intracellular ATP3.  There are three types of  ATPase: 
P-type ATPases, V-type ATPases and ABC transporters 
for ATP binding cassette.  The distinguishing function-
al characteristic of  P-type ATPases is that the hydrolysis 
of  ATP that occurs during the catalytic cycle results in 
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the phosphorylation of  the transport protein itself. This 
phosphorylation results in a change in the conformation 
of  the protein that, in turn, plays a part in the transloca-
tion of  one or more substrate molecules across the mem-
brane4.
Erythrocyte Na+, K+-ATPase, and Ca-2+, Mg-2+ -ATPase 
activity in young individuals were markedly lower than 
that in the adults.  Intra-erythrocyte free Ca-2+ concentra-
tion in young individuals was markedly higher than that 
in adults3.  The two ATPases activity in the elderly group 
over 60 years old were lower than that in young individ-
uals, intra-erythrocytic free Ca-2+ concentration in the el-
derly group was higher than that in young individuals.  In 
all age groups, the three parameters mentioned above in 
young individuals showed most remarkable change with 
aging and that changes in young females were more re-
markable than that in young males5.
Placenta showed an increase of  Na+, K+ -ATPase on day 
21 of  gestation in comparison to day 126. Erythrocyte 
Na+, K+-ATPase activity was normal in pregnant wom-
en, suggesting that the peripheral metabolic status during 
pregnancy was normal.  Increases in both the number 
and function of  the pump may be influenced by factors 
other than thyroid function7.
The red-blood cell membrane possesses an ATP-depen-
dent transport system by which the hydrolysis of  one 
molecule of  ATP results in the linked movement of  three 
Na+ ions out of  the cell and two K+ ions into the cell. 
This active transport process is dependent upon the ap-
propriate concentrations of  Na+ and K+ inside and out-
side of  the cell membrane, and is specifically inhibited by 
low concentrations of  cardiac glycosides8. 
The Na+ transport system represents a complex pro-
tein-lipid moiety appropriately orientated within the 
membrane.  The number of  Na+ and K+ transport sites 
per red cell has been calculated from kinetic data and 
from the binding of  tritium-labeled ouabain to be ap-
proximately 200 per cell 9-11.
The rationale for this study was the possible utility of  
erythrocyte ATPase as a biomarker of  physiological 
changes in human bodies. This will help in early diagnosis 
of  health status.
 
The aim of  this study was to find out the possibility of  
using Na+-K+ATPase specific activity as a biomarker for 




Sucrose, magnesium chloride hexahydrate, ascorbic acid, 
sodium chloride, potassium chloride, ammonium mo-
lybdate, ethylenediaminetatra-acetic acid (EDTA), sodi-
um hydroxide, sodium dodecyl sulphate (SDS), sulfuric 
acid , hydrochloric acid and Tris tris [hydroxymethyl] 
aminoethane were purchased from BDH limited Poole, 
England.  Adenosine-5`- triphosphate disodum salt and 
ouabain were obtained from Sigma Chemical Company 
St. Louis, MO, USA.
 
Subjects
Human subjects included in this study were selected from 
four different hospitals in Jeddah area of  Saudi Arabia, 
King Abdulaziz University Hospital, King Fahd Hospital, 
Al Thaqer Hospital and Maternity Hospital.
Total of  149 subjects were included in this study and di-
vided into two main groups.  The first group consisted 
of  63 normal healthy individuals of  the age 23-50 years 
and this group was used as a control. This control group 
consisted of  34 males and 27 females.  The second group 
(n=86) consisted of  subjects with physiological / condi-
tions which include pregnancy (n=21), smoking (n=30)
and pathological conditions such as  diabetes (n=20) and 
kidney disease (n=15).  Detailed history, mental, physical 
status and clinical examination showed that the control 
group consisted of  completely healthy individuals and 
had not been subject to any therapeutic drugs during the 
past 4 months of  blood sampling.  Patients with different 
physiological changes were confirmed by clinical and bio-
chemical examinations.  The subjects were informed of  
their consent prior to drawing blood samples.
A venous blood sample 5ml was collected in a heparin’s 
tube from each subject and kept in an icebox.  Plasma was 
separated by centrifugation at 4500 rpm at 4oC.  Precipi-
tated RBC’s were washed by isotonic solution 0.9 % w/v 
NaCl, throughout; this step was repeated three times. 
Another wash with de-ionaized water was performed, 
and then stored at –20oC overnight.  After thawing, the 
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supernatant was separated by centrifugation at 8000 rpm 
for 30 min, and RBC was used for the Na+-K+ ATPase 
assay.
Determination of  the Na+, K+ -ATPase activity 
The ATPase activity was quantified by measuring the re-
lease of  Pi from ATP Serrano, 1978.  A spectrophoto-
metric method was adopted, the quantity of  Pi in the as-
say was then determined spectrophotometrically against 
a standard curve derived from solution of  known phos-
phate concentration12.  One ml of  RBC homogenate 
was added to ATPase buffer 50 mM Tris, 3 mM MgCl2. 
6H2O, 10 mM KCl, 0.1 mM EDTA, 100 mM NaCl at 
pH 7.4 and +/- Ouabine. Incubated for 5 min at 37oC 
in water bath then 2 mM ATP was added and incubated 
further for 10 min.  Ammonium molybdate solution 2 
ml was added to stop the reaction23.  By adding 20 µl of  
ascorbic acid, the absorbance of  color complex was mea-
sured at 750 nm13. The calorimetric method was applied 
for the measurement of  total protein according to the 
method of  Biuret14.
Statistical analysis
The data were logged into personal computer and anal-
yses of  data were performed using SPSS statistical pack-
age version 22.  T-test was used for comparing means.  P 
value was considered to be statistically significant if  it was 
< 0.005.
Results
In pregnancy, as shown in Figure 1, the mean activity of  
Na+, K+ -ATPase of  healthy females (n= 21) was com-
pared with pregnant women of  the same age group.  The 
mean of  enzyme activity for pregnant women 0.0094 
± 0.001 nmol Pi/min. mg protein was higher than in 
healthy women 0.0086 ± 0.001 nmol Pi/min. mg pro-
tein and there was a highly significant difference between 








Figure 1:The mean values of Na+, K+ -ATPase specific activity of pregnant females 
compared to non-pregnant at same age p<0.01. 
  
 
Figure 1:The mean values of Na+, K+ -ATPase specific activity of pregnant females compared to non-pregnant at 
same age (p<0.01). 
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In smokers, as shown in Figure 2, the activity of  Na+, K+ 
-ATPase for non-smokers individuals at ages 23-50 years 
was compared to smokers of  the same age group. The 
enzyme activity of  healthy, non-smokers 0.0081 ±  0.001 
nmol Pi/min. mg protein was higher compared to smok-
ers 0.0064 ±  0.001 nmol Pi/min. mg protein.  There was 








Figure 2: The mean values of Na+, K+ -ATPase specific activity of smokers compared 
to no smokers p<0.001 . 
  
In diabetics, as shown in Figure 3 the enzyme activity of  
the patients was (n= 20) compared to healthy individuals 
(males and females) at 23-50 age group.  The mean activ-
ity of  Na+, K+ -ATPase for healthy group was 0.0081±  
0.001 nmol Pi/min. mg protein, which was higher than in 
diabetes patients (0.0047 ±  0.002 nmol Pi/min. mg pro-
tein) and the difference was highly significant P= 0.000.
In kidney disease patients, as shown Figure 4 the enzyme 
activity of  the n= 15 was compared with healthy individ-
uals (males and females) at 23-50 age group.  The mean 
activity of  Na+, K+ -ATPase for healthy individuals was 
0.0081 ±  0.001 nmol Pi/min. mg protein, which high-
er compared to kidney diseases patients 0.0069 ±  0.001 
nmol Pi/min. mg protein and the difference was highly 
significant (P= 0.000).
No significant difference in ATPase activity between 
males and females.
 
Figure 2: The mean values of  Na+, K+ -ATPase specific activity of smokers compared to no smokers (p<0.001) . 







Figure 3: The mean values of Na+, K+ -ATPase specific activity of diabetes patient 







Figure 4: The mean values of Na+, K+ -ATPase specific activity of healthy males 
and females at age 23-50 years compared to kidney diseased p<0.05 . 
  
 
Figure 3: The mean values of  Na+, K+ -ATPase specific activity of diabetes patient compared with normal at same 
age (p<0.01). 
 
Figure 4: The mean values of  Na+, K+ -ATPase specific activity of healthy males and females at age 23-50 years 
compared to kidney disease (p<0.05). 
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Discussion
The Na+/K+-ATPase is a membrane enzyme which is 
involved in the regulation of  membrane potential, cell 
permeability of  Na+, K+ and Ca2+ and excitatory neu-
rotransmitters. It is also important in cell cycle and dif-
ferentiation. The balance of  Na+ and K+ between the 
intracellular and extracellular is the main requirement for 
cellular homeostasis and for different functions3. The ra-
tionale of  this study was the possibility of  utilization of  
Na+/K+-ATPase as a biomarker for blood diseases.
 Previous reports stated that, there is an elevation of  Na+, 
K+-ATPase activity in the primary anemia patients. This 
elevation may be a compensating mechanism for adapta-
tion of  the patients with low oxygen and its physiological 
role in the cell14.
It is assumed that any change in the micro-environmen-
tof  blood will have an effect on Na+, K+ -ATPase activ-
ity in the red cell membranes. To verify this assumption, 
the activity of  Na+, K+ -ATPase from healthy individuals 
with different genders but same age group control were 
compared to those with different physiological condi-
tions. Physiological changes in blood environment are re-
lated most of  the time with alteration in enzyme specific 
activity which might be due to increased / decreased con-
centration of  ions, biochemical materials or changes in 
membrane components and/or structures that is related 
to that changes.
The result obtained from this study indicated that the 
mean specific activity of  Na+, K+ -ATPase of  pregnant 
women is higher than the healthy women with highly 
statistically significant difference.  This agrees well with 
published results25.  This might be due to enzyme relative 
contribution either to metabolite transport process or/
and to the thermogenesis during pregnancy.  However, 
the increases in both the number and function of  the 
pump may be influenced by factors other than thyroid 
function26. The mean value of  specific activity of  Na+, 
K+-ATPase for healthy individuals are higher compared 
to smokers of  the same ages group and gender.  This 
is in agreement with result obtained by Tulenko et al25, 
where they reported that the Na+, K+ -ATPase activity 
was decreased in smoker subjects compared with non-
smokers.  The suppression in enzyme activity was related 
to increase in Na+ level inside cell.  It was suggested that, 
chronic cigarette smoking causes changes in phospholip-
id bilayer in cell membrane of  blood wall26. 
The result obtained here indicated that the mean specific 
activity of  Na+, K+ -ATPase of  healthy individuals are 
higher than individuals with diabetes of  the same age 
group and gender, which might be due to the insulin lev-
el.  If  insulin level is low, the rate of  glycolysis in red cell 
become low and leads consequently to decrease the level 
of  ATP so there would be a decreased in the enzyme ac-
tivity27.  In vitro insulin treatment of  diabetic red cells was 
found to inhibit the further increase in its activity, but it 
failed to restore the activity to the normal level26.
The mean value of  specific activity of  Na+, K+ -ATPase 
for healthy individuals is higher compared to the kidney 
disease patients at the same age and gender, and the dif-
ference is highly significant.  This might due to alteration 
in the ions in blood environment in kidney disease pa-
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